TTOO - T2 Biosystems names Brett Giffin as chief commercial officer

T2 Biosystems (NASDAQ:TTOO) announces the appointment of Brett Giffin as its Chief Commercial Officer, effective November 8, 2021. Giffin brings a wealth of industry experience and commercial leadership to T2 Biosystems, having served as Chief Executive Officer for two early stage medical technology companies, among other things. He will join the company’s executive leadership team and lead its commercial growth initiatives with direct responsibility for global sales, marketing, service, and customer support functions.

For further details see:

T2 Biosystems names Brett Giffin as chief commercial officer